Publications by authors named "Charles Meng"

Claim this Profile
T
TNFR1 Suppression by XPro1595 Reduces Peripheral Neuropathies Associated with Perineural Invasion in Female Mice.
Morgan Zhang, Naijiang Liu, Kesava Asam, Charles Meng, Bradley Aouizerat

Cells· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.
Charles Q Meng, Liming Ni, Kimberly J Worsencroft, Zhihong Ye, M David Weingarten

J Med Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherosclerosis is an inflammatory disorder after all.
Charles Q Meng

Curr Top Med Chem· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expression.
Charles Kunsch, Jayraz Luchoomun, Xi-Lin Chen, Geraldine L Dodd, Kanika S Karu, Charles Q Meng

J Pharmacol Exp Ther· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation in atherosclerosis: new opportunities for drug discovery.
Charles Q Meng

Mini Rev Med Chem· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.
Charles Q Meng, Patricia K Somers, Lee K Hoong, X Sharon Zheng, Zhihong Ye

J Med Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new era in atherosclerosis drug discovery.
Charles Q Meng

Expert Rev Cardiovasc Ther· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.
Charles Q Meng, X Sharon Zheng, Liming Ni, Zhihong Ye, Jacob E Simpson

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Cynthia L Sundell, Patricia K Somers, Charles Q Meng, Lee K Hoong, Ki-Ling Suen

J Pharmacol Exp Ther· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDL Cholesterol 2003--Fourth Annual International Conference. Metabolic pathways and drug targets. 2-4 March 2003, Cambridge, MA, USA.
Charles Q Meng

IDrugs· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BO-653. Chugai.
Charles Q Meng

Curr Opin Investig Drugs· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead discovery of alpha,beta-unsaturated sulfones from a combinatorial library as inhibitors of inducible VCAM-1 expression.
Liming Ni, X Sharon Zheng, Patricia K Somers, Lee K Hoong, Russell R Hill, Charles Q Meng

Bioorg Med Chem Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease.
Martin A Wasserman, Cynthia L Sundell, Charles Kunsch, David Edwards, Charles Q Meng

Am J Cardiol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis.
Charles Q Meng, Patricia K Somers, Carolyn L Rachita, Lisa A Holt, Lee K Hoong

Bioorg Med Chem Lett· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ezetimibe. Schering-Plough.
Charles Q Meng

Curr Opin Investig Drugs· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis